do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation The effect of inhibitors, and SGLT-2 on cardiorenal outcomes: a network meta-analysis of 23 CVOTs | Cardiovascular Diabetology Can dipeptidyl peptidase‑4 (DPP‑4) inhibitors
Description
Lorcaserin was approved by the FDA in 2012 for use as an adjunct to a diet and exercise program for the treatment of obesity
Sour orange is a citrus species have traditionally been utilized as medicinal herbs within the Rutaceae family in Eastern cultures
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)
Pi-Sun et al., 2015
Such mechanisms involve ischemic coronary artery disease, hypertension, or valvular disease, leading to cardiac hypertrophy and fibrosis
doi: 10.1136/bmjpo-2019-000624
95% CI: 0.90 to 0.93
